N-[(3S)-2,6-dioxopiperidin-3-yl]-12-[[(3R)-8-[4-[(3S,4R)-7-hydroxy-3-phenyl-3,4-dihydro-2H-chromen-4-yl]phenyl]-1-oxa-8-azaspiro[4.5]decan-3-yl]methyl]-8-oxa-1,6,12-triazatricyclo[8.4.0.02,7]tetradeca-2(7),3,5-triene-5-carboxamide

C46H50N6O7 — CID 170728567

IUPACN-[(3S)-2,6-dioxopiperidin-3-yl]-12-[[(3R)-8-[4-[(3S,4R)-7-hydroxy-3-phenyl-3,4-dihydro-2H-chromen-4-yl]phenyl]-1-oxa-8-azaspiro[4.5]decan-3-yl]methyl]-8-oxa-1,6,12-triazatricyclo[8.4.0.02,7]tetradeca-2(7),3,5-triene-5-carboxamide
SMILESO=C1CC[C@H](NC(=O)c2ccc3c(n2)OCC2CN(C[C@@H]4COC5(CCN(c6ccc([C@@H]7c8ccc(O)cc8OC[C@@H]7c7ccccc7)cc6)CC5)C4)CCN32)C(=O)N1
InChIInChI=1S/C46H50N6O7/c53-34-10-11-35-40(22-34)57-28-36(30-4-2-1-3-5-30)42(35)31-6-8-32(9-7-31)51-18-16-46(17-19-51)23-29(26-59-46)24-50-20-21-52-33(25-50)27-58-45-39(52)14-12-38(48-45)43(55)47-37-13-15-41(54)49-44(37)56/h1-12,14,22,29,33,36-37,42,53H,13,15-21,23-28H2,(H,47,55)(H,49,54,56)/t29-,33?,36-,37+,42-/m1/s1
InChIKeyJTVVMXJVTIJQEP-DLIJJRDGSA-N
MW798.94 g/mol
LogP4.59
Rot. Bonds7

About N-[(3S)-2,6-dioxopiperidin-3-yl]-12-[[(3R)-8-[4-[(3S,4R)-7-hydroxy-3-phenyl-3,4-dihydro-2H-chromen-4-yl]phenyl]-1-oxa-8-azaspiro[4.5]decan-3-yl]methyl]-8-oxa-1,6,12-triazatricyclo[8.4.0.02,7]tetradeca-2(7),3,5-triene-5-carboxamide

N-[(3S)-2,6-dioxopiperidin-3-yl]-12-[[(3R)-8-[4-[(3S,4R)-7-hydroxy-3-phenyl-3,4-dihydro-2H-chromen-4-yl]phenyl]-1-oxa-8-azaspiro[4.5]decan-3-yl]methyl]-8-oxa-1,6,12-triazatricyclo[8.4.0.02,7]tetradeca-2(7),3,5-triene-5-carboxamide (PubChem CID 170728567) has the molecular formula C46H50N6O7 and a molecular weight of 798.94 g/mol. Its IUPAC name is N-[(3S)-2,6-dioxopiperidin-3-yl]-12-[[(3R)-8-[4-[(3S,4R)-7-hydroxy-3-phenyl-3,4-dihydro-2H-chromen-4-yl]phenyl]-1-oxa-8-azaspiro[4.5]decan-3-yl]methyl]-8-oxa-1,6,12-triazatricyclo[8.4.0.02,7]tetradeca-2(7),3,5-triene-5-carboxamide.

Molecular Properties

Compound NameN-[(3S)-2,6-dioxopiperidin-3-yl]-12-[[(3R)-8-[4-[(3S,4R)-7-hydroxy-3-phenyl-3,4-dihydro-2H-chromen-4-yl]phenyl]-1-oxa-8-azaspiro[4.5]decan-3-yl]methyl]-8-oxa-1,6,12-triazatricyclo[8.4.0.02,7]tetradeca-2(7),3,5-triene-5-carboxamide
PubChem CID170728567
Molecular FormulaC46H50N6O7
Molecular Weight798.94 g/mol
Exact Mass798.37
IUPAC NameN-[(3S)-2,6-dioxopiperidin-3-yl]-12-[[(3R)-8-[4-[(3S,4R)-7-hydroxy-3-phenyl-3,4-dihydro-2H-chromen-4-yl]phenyl]-1-oxa-8-azaspiro[4.5]decan-3-yl]methyl]-8-oxa-1,6,12-triazatricyclo[8.4.0.02,7]tetradeca-2(7),3,5-triene-5-carboxamide
SMILESO=C1CC[C@H](NC(=O)c2ccc3c(n2)OCC2CN(C[C@@H]4COC5(CCN(c6ccc([C@@H]7c8ccc(O)cc8OC[C@@H]7c7ccccc7)cc6)CC5)C4)CCN32)C(=O)N1
InChIInChI=1S/C46H50N6O7/c53-34-10-11-35-40(22-34)57-28-36(30-4-2-1-3-5-30)42(35)31-6-8-32(9-7-31)51-18-16-46(17-19-51)23-29(26-59-46)24-50-20-21-52-33(25-50)27-58-45-39(52)14-12-38(48-45)43(55)47-37-13-15-41(54)49-44(37)56/h1-12,14,22,29,33,36-37,42,53H,13,15-21,23-28H2,(H,47,55)(H,49,54,56)/t29-,33?,36-,37+,42-/m1/s1
InChIKeyJTVVMXJVTIJQEP-DLIJJRDGSA-N
XLogP4.59
TPSA145.80 Ų
H-Bond Donors3
H-Bond Acceptors11
Rotatable Bonds7
Heavy Atoms59
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500798.94
LogP ≤ 54.59
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1011

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'anil_di_alk_E(186)', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze N-[(3S)-2,6-dioxopiperidin-3-yl]-12-[[(3R)-8-[4-[(3S,4R)-7-hydroxy-3-phenyl-3,4-dihydro-2H-chromen-4-yl]phenyl]-1-oxa-8-azaspiro[4.5]decan-3-yl]methyl]-8-oxa-1,6,12-triazatricyclo[8.4.0.02,7]tetradeca-2(7),3,5-triene-5-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(3S)-2,6-dioxopiperidin-3-yl]-12-[[(3R)-8-[4-[(3S,4R)-7-hydroxy-3-phenyl-3,4-dihydro-2H-chromen-4-yl]phenyl]-1-oxa-8-azaspiro[4.5]decan-3-yl]methyl]-8-oxa-1,6,12-triazatricyclo[8.4.0.02,7]tetradeca-2(7),3,5-triene-5-carboxamide?
The IUPAC name of N-[(3S)-2,6-dioxopiperidin-3-yl]-12-[[(3R)-8-[4-[(3S,4R)-7-hydroxy-3-phenyl-3,4-dihydro-2H-chromen-4-yl]phenyl]-1-oxa-8-azaspiro[4.5]decan-3-yl]methyl]-8-oxa-1,6,12-triazatricyclo[8.4.0.02,7]tetradeca-2(7),3,5-triene-5-carboxamide (CID 170728567) is N-[(3S)-2,6-dioxopiperidin-3-yl]-12-[[(3R)-8-[4-[(3S,4R)-7-hydroxy-3-phenyl-3,4-dihydro-2H-chromen-4-yl]phenyl]-1-oxa-8-azaspiro[4.5]decan-3-yl]methyl]-8-oxa-1,6,12-triazatricyclo[8.4.0.02,7]tetradeca-2(7),3,5-triene-5-carboxamide.
What is the SMILES notation for N-[(3S)-2,6-dioxopiperidin-3-yl]-12-[[(3R)-8-[4-[(3S,4R)-7-hydroxy-3-phenyl-3,4-dihydro-2H-chromen-4-yl]phenyl]-1-oxa-8-azaspiro[4.5]decan-3-yl]methyl]-8-oxa-1,6,12-triazatricyclo[8.4.0.02,7]tetradeca-2(7),3,5-triene-5-carboxamide?
The canonical SMILES for N-[(3S)-2,6-dioxopiperidin-3-yl]-12-[[(3R)-8-[4-[(3S,4R)-7-hydroxy-3-phenyl-3,4-dihydro-2H-chromen-4-yl]phenyl]-1-oxa-8-azaspiro[4.5]decan-3-yl]methyl]-8-oxa-1,6,12-triazatricyclo[8.4.0.02,7]tetradeca-2(7),3,5-triene-5-carboxamide is O=C1CC[C@H](NC(=O)c2ccc3c(n2)OCC2CN(C[C@@H]4COC5(CCN(c6ccc([C@@H]7c8ccc(O)cc8OC[C@@H]7c7ccccc7)cc6)CC5)C4)CCN32)C(=O)N1.
What is the InChIKey of N-[(3S)-2,6-dioxopiperidin-3-yl]-12-[[(3R)-8-[4-[(3S,4R)-7-hydroxy-3-phenyl-3,4-dihydro-2H-chromen-4-yl]phenyl]-1-oxa-8-azaspiro[4.5]decan-3-yl]methyl]-8-oxa-1,6,12-triazatricyclo[8.4.0.02,7]tetradeca-2(7),3,5-triene-5-carboxamide?
The InChIKey is JTVVMXJVTIJQEP-DLIJJRDGSA-N. The full InChI is InChI=1S/C46H50N6O7/c53-34-10-11-35-40(22-34)57-28-36(30-4-2-1-3-5-30)42(35)31-6-8-32(9-7-31)51-18-16-46(17-19-51)23-29(26-59-46)24-50-20-21-52-33(25-50)27-58-45-39(52)14-12-38(48-45)43(55)47-37-13-15-41(54)49-44(37)56/h1-12,14,22,29,33,36-37,42,53H,13,15-21,23-28H2,(H,47,55)(H,49,54,56)/t29-,33?,36-,37+,42-/m1/s1.
What are the key properties of N-[(3S)-2,6-dioxopiperidin-3-yl]-12-[[(3R)-8-[4-[(3S,4R)-7-hydroxy-3-phenyl-3,4-dihydro-2H-chromen-4-yl]phenyl]-1-oxa-8-azaspiro[4.5]decan-3-yl]methyl]-8-oxa-1,6,12-triazatricyclo[8.4.0.02,7]tetradeca-2(7),3,5-triene-5-carboxamide?
N-[(3S)-2,6-dioxopiperidin-3-yl]-12-[[(3R)-8-[4-[(3S,4R)-7-hydroxy-3-phenyl-3,4-dihydro-2H-chromen-4-yl]phenyl]-1-oxa-8-azaspiro[4.5]decan-3-yl]methyl]-8-oxa-1,6,12-triazatricyclo[8.4.0.02,7]tetradeca-2(7),3,5-triene-5-carboxamide has a molecular weight of 798.94 g/mol, XLogP of 4.59, 7 rotatable bonds, 3 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(3S)-2,6-dioxopiperidin-3-yl]-12-[[(3R)-8-[4-[(3S,4R)-7-hydroxy-3-phenyl-3,4-dihydro-2H-chromen-4-yl]phenyl]-1-oxa-8-azaspiro[4.5]decan-3-yl]methyl]-8-oxa-1,6,12-triazatricyclo[8.4.0.02,7]tetradeca-2(7),3,5-triene-5-carboxamide is sourced from PubChem (CID 170728567), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).